When to switch? Anti-CGRPs and gepants
Session 1: New treatments – Evaluation and management
Bianca Raffaelli
Neurology consultant, Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
Previous
When to evaluate effectiveness?- Anti-CGRPs and gepants
Next